Concepedia
Statistics
Publications
7
Citations
328
H-Index
Active since
2001
Affiliations
Menlo School(Current)
Start Treatment & Recovery Centers
South Texas Accelerated Research Therapeutics
National Institutes of Health Clinical Center
Isagani Chico is an author at Menlo School specializing in oncology, medicine, and pharmacology.
Publications per year
2001–2024
Phase I Study of Infusional Paclitaxel in Combination With the P-Glycoprotein Antagonist PSC 833
Isagani Chico, Min H. Kang, Raymond C. Bergan et al. · Journal of Clinical Oncology · 2001 · 89 citations
Pharmacy, Pharmacokinetics, Pharmacology +16
A Phase I study of infusional vinblastine in combination with the p-glycoprotein antagonist PSC 833 (valspodar)
Susan E. Bates, Min H. Kang, Beverly Meadows et al. · Cancer · 2001 · 80 citations · Full text
Pharmacy, Pharmacology, Pharmacotherapy +15
A phase Ib/II study of the anti-CD47 antibody magrolimab with cetuximab in solid tumor and colorectal cancer patients.
George A. Fisher, Nehal J. Lakhani, Cathy Eng et al. · Journal of Clinical Oncology · 2020 · 53 citations
Medicine, Oncology, Pharmacology +15
A phase Ib study of the anti-CD47 antibody magrolimab with the PD-L1 inhibitor avelumab (A) in solid tumor (ST) and ovarian cancer (OC) patients.
Nehal J. Lakhani, Amita Patnaik, John B. Liao et al. · Journal of Clinical Oncology · 2020 · 37 citations
Medicine, Oncology, Pharmacology +17
Role of decentralized clinical trials in cancer drug development: Results from a survey of oncologists and patients
Begoña de las Heras, Adam Daehnke, Kamal S. Saini et al. · Digital Health · 2022 · 27 citations · Full text
Medicine, Oncology, Clinical Data Management +15
1–5 of 7